Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: MAPP BIOPHARMACEUTICAL, INC.
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2020-07-28 to 2023-02-28
Current total value of award: $1499004.12
Description: STTR PHASE II